ATE339434T1 - Basenanaloge - Google Patents

Basenanaloge

Info

Publication number
ATE339434T1
ATE339434T1 AT01947617T AT01947617T ATE339434T1 AT E339434 T1 ATE339434 T1 AT E339434T1 AT 01947617 T AT01947617 T AT 01947617T AT 01947617 T AT01947617 T AT 01947617T AT E339434 T1 ATE339434 T1 AT E339434T1
Authority
AT
Austria
Prior art keywords
alkynyl
sugar
alkenyl
novel compounds
alkyl
Prior art date
Application number
AT01947617T
Other languages
English (en)
Inventor
Shiv Kumar
Mark Mcdougall
Satyam Nampalli
Constantin Neagu
David Loakes
Dan Brown
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Res Council filed Critical Medical Res Council
Application granted granted Critical
Publication of ATE339434T1 publication Critical patent/ATE339434T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/117—Modifications characterised by incorporating modified base

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Laminated Bodies (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT01947617T 2000-07-03 2001-06-29 Basenanaloge ATE339434T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0016258.6A GB0016258D0 (en) 2000-07-03 2000-07-03 Base analogues

Publications (1)

Publication Number Publication Date
ATE339434T1 true ATE339434T1 (de) 2006-10-15

Family

ID=9894887

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01947617T ATE339434T1 (de) 2000-07-03 2001-06-29 Basenanaloge

Country Status (11)

Country Link
US (1) US6664058B2 (de)
EP (1) EP1296997B1 (de)
JP (1) JP2004502701A (de)
AT (1) ATE339434T1 (de)
AU (1) AU2001269264A1 (de)
CA (1) CA2412292A1 (de)
DE (1) DE60123056T2 (de)
DK (1) DK1296997T3 (de)
ES (1) ES2271036T3 (de)
GB (1) GB0016258D0 (de)
WO (1) WO2002002584A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780591B2 (en) 1998-05-01 2004-08-24 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US7875440B2 (en) 1998-05-01 2011-01-25 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US6818395B1 (en) 1999-06-28 2004-11-16 California Institute Of Technology Methods and apparatus for analyzing polynucleotide sequences
US7501245B2 (en) 1999-06-28 2009-03-10 Helicos Biosciences Corp. Methods and apparatuses for analyzing polynucleotide sequences
JP2004523243A (ja) 2001-03-12 2004-08-05 カリフォルニア インスティチュート オブ テクノロジー 非同期性塩基伸長によってポリヌクレオチド配列を分析するための方法および装置
US7169560B2 (en) 2003-11-12 2007-01-30 Helicos Biosciences Corporation Short cycle methods for sequencing polynucleotides
ATE463584T1 (de) 2004-02-19 2010-04-15 Helicos Biosciences Corp Verfahren zur analyse von polynukleotidsequenzen
EP1766090B1 (de) 2004-05-25 2011-04-27 Helicos Biosciences Corporation Verfahren zur nukleinsäureimmobilisierung
US7476734B2 (en) 2005-12-06 2009-01-13 Helicos Biosciences Corporation Nucleotide analogs
US7220549B2 (en) 2004-12-30 2007-05-22 Helicos Biosciences Corporation Stabilizing a nucleic acid for nucleic acid sequencing
US7482120B2 (en) 2005-01-28 2009-01-27 Helicos Biosciences Corporation Methods and compositions for improving fidelity in a nucleic acid synthesis reaction
US7666593B2 (en) 2005-08-26 2010-02-23 Helicos Biosciences Corporation Single molecule sequencing of captured nucleic acids
US7397546B2 (en) 2006-03-08 2008-07-08 Helicos Biosciences Corporation Systems and methods for reducing detected intensity non-uniformity in a laser beam
CN111818877B (zh) 2018-01-25 2023-12-22 爱德华兹生命科学公司 在部署后用于辅助置换瓣膜重新捕获和重新定位的递送系统
ES2969883T3 (es) 2018-03-21 2024-05-23 Hoffmann La Roche ADN polimerasas para la incorporación eficiente y eficaz de dNTP metilados
WO2020033791A1 (en) 2018-08-09 2020-02-13 Verseau Therapeutics, Inc. Oligonucleotide compositions for targeting ccr2 and csf1r and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9602025D0 (en) * 1996-02-01 1996-04-03 Amersham Int Plc Nucleoside analogues
GB9716231D0 (en) * 1997-07-31 1997-10-08 Amersham Int Ltd Base analogues

Also Published As

Publication number Publication date
WO2002002584A1 (en) 2002-01-10
US20020137695A1 (en) 2002-09-26
CA2412292A1 (en) 2002-01-10
DK1296997T3 (da) 2007-01-02
EP1296997B1 (de) 2006-09-13
GB0016258D0 (en) 2000-08-23
DE60123056T2 (de) 2007-01-18
DE60123056D1 (de) 2006-10-26
ES2271036T3 (es) 2007-04-16
US6664058B2 (en) 2003-12-16
JP2004502701A (ja) 2004-01-29
AU2001269264A1 (en) 2002-01-14
EP1296997A1 (de) 2003-04-02

Similar Documents

Publication Publication Date Title
DK1296997T3 (da) Baseanaloger
EP1013661A4 (de) Bicyclonukleosid- und oligonukleotid-analoga
ATE232880T1 (de) Neue nucleotidanaloga
DE60114525D1 (de) Array-basierende Methoden zur Synthese von Nukleinsäuregemischen
ATE154029T1 (de) 7-deazapurin modifizierte oligonukleotide
DE60015388D1 (de) Zusammensetzung daraus hergestellte gegenstände
WO2000061151A3 (en) Oligodeoxynucleotide and its use to induce an immune response
PL328639A1 (en) Synthesis of p5' phosphoamidane oligonucleotides n3'
DK1218545T3 (da) Fremgangsmåder til fremstilling af oligonukleotidopløsninger
ATE251131T1 (de) Feinteilige form von (s)-2-ethoxy -3- 4-(2- 4- methansulfonyloxyphenyl ethoxy)phenyl)propansäure
EP2157083A3 (de) Pharmazeutische Zusammensetzungen mit Kristalline Form (I) von Lercanidipin-Hydrochlorid
WO2000040590A3 (fr) Compose fonctionnalise, polynucleotide eventuellement marque et procede de detection d'un acide nucleique cible
DE60018422D1 (de) Typ v pde-hemmer zur behandlung von mukoviszidose
DE502004009152D1 (de) Verfahren zur herstellung von derivaten des 4a,5,9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
EP1829861A3 (de) Als Oxytocinantagonisten wirksame Pyrrolidinesterderivate
WO2002044398A3 (en) Universal supports for oligonucleotide synthesis
DE60203998D1 (de) Verfahren zur herstellung von (e)-5-(2-bromovinyl)-2'-deoxyuridin
DE60335805D1 (de) Verfahren zur herstellung von 1,3-dioxolan-nucleosiden
DE59914714D1 (de) Herstellung von fluoridarmen organischen Verbindungen
EP1312608A3 (de) Discodermolid-Analoga und ihre pharmazeutische Verwendung
DE60230097D1 (de) Verfahren zur herstellung von 1,5-diaminonaphthalinen
DE59809538D1 (de) Verfahren zur Herstellung von 1,2,3,6-Tetrahydro-2,2,6,6-tetramethylpyridin
DE50107987D1 (de) Verfahren zur herstellung von 2,3,5,6-tetrahalogen-xylylidenverbindungen
EP1300395A4 (de) 4-substituierte piperidinverbindung
DK1537210T3 (da) Decoy-oligonukleotid-inhibering af CD40-ekspression

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties